Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Susan S. Smyth's research focuses on the study of thrombosis and related biomarkers, particularly in the context of COVID-19. She has investigated extracellular histones as triggers for disseminated intravascular coagulation and examined von Willebrand factor and extracellular vesicles as biomarkers for thrombosis in COVID-19 patients. Her work also includes comparing the effects of ticagrelor and clopidogrel on platelet aggregation and inflammation in patients with chronic kidney disease.
Beyond her primary research on thrombotic risk, Smyth has contributed to studies on clinical practice guideline implementation in emergency departments, focusing on syncope evaluation and management from a patient perspective. She has also explored factors contributing to career success for KL2 scholars in translational science and examined the topic of menopause in the workplace.
Smyth leads a research group and has a publication record of 78 works, with an h-index of 20 and 1,739 citations. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Jerry Ware and Nishank Jain.
Metrics
- h-index: 20
- Publications: 78
- Citations: 1,739
Selected Publications
-
Neurotensin accelerates atherosclerosis and increases circulating levels of short-chain and saturated triglycerides (2024)
-
438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease (2023)
-
Co-designing and piloting educational materials with patients and healthcare providers for syncope in the emergency department (2023)
-
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease (2023)
-
Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death (2022)
-
Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death (2022)
-
Bioactive lipids and metabolic syndrome—a symposium report (2022)
-
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium (2022)
-
KL2 scholars’ perceptions of factors contributing to sustained translational science career success (2021)
-
Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool (2021)
-
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles (2021)
Collaboration Network
Top Collaborators
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
- “Passing Out is a Serious Thing”: Patient Expectations for Syncope Evaluation and Management
- KL2 scholars’ perceptions of factors contributing to sustained translational science career success
- Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
Showing 5 of 6 shared publications
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
- “Passing Out is a Serious Thing”: Patient Expectations for Syncope Evaluation and Management
- Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
- Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center
Showing 5 of 6 shared publications
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
- “Passing Out is a Serious Thing”: Patient Expectations for Syncope Evaluation and Management
- Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
- Co-designing and piloting educational materials with patients and healthcare providers for syncope in the emergency department
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
- “Passing Out is a Serious Thing”: Patient Expectations for Syncope Evaluation and Management
- Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
- Co-designing and piloting educational materials with patients and healthcare providers for syncope in the emergency department
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
- “Passing Out is a Serious Thing”: Patient Expectations for Syncope Evaluation and Management
- Planning Implementation Success of Syncope Clinical Practice Guidelines in the Emergency Department Using CFIR Framework
- Co-designing and piloting educational materials with patients and healthcare providers for syncope in the emergency department
- Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death
- Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death
- Inflammasome activation promotes venous thrombosis through pyroptosis
- Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis
- Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death
- Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death
- Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis
- “Passing Out is a Serious Thing”: Patient Expectations for Syncope Evaluation and Management
- Developing and Demonstrating the Viability and Availability of the Multilevel Implementation Strategy for Syncope Optimal Care Through Engagement (MISSION) Syncope App: Evidence-Based Clinical Decision Support Tool
- Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
- COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles
- Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death
- Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death
- Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death
- Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death
- Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death
- Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death
- Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death
- Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death
- Extracellular Histones Trigger Disseminated Intravascular Coagulation by Lytic Cell Death
- Abstract 487: Extracellularhistonestrigger Disseminated Intravascular Coagulation By Lytic Cell Death
- Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease
- 438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease
Similar Researchers
Based on overlapping research topics